Information about Iqvia Cancer Research
My details
*
*
*

Iqvia Cancer Research (SRL)

Company information

Status
Active

Enterprise number

BE0763.914.095

VAT liability
Yes
Established
22-02-2021
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Iqvia Cancer Research

2024 2023 2022 2021
Profit/Loss 2,686 103 % -102,166 13 % -117,893 -29 % -91,252
Equity -308,526 1 % -311,212 -49 % -209,046 -129 % -91,152
Gross margin 18,152 121 % -85,978 24 % -112,966 -25 % -90,730

Publications from Iqvia Cancer Research

Date Publication
18-10-2023 Resignations - Appointments (NL)
24-02-2021 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Iqvia Cancer Research?
The VAT number of Iqvia Cancer Research is BE 0763.914.095.
Wat is the PEPPOL ID of Iqvia Cancer Research?
There is no information available about the PEPPOL ID of Iqvia Cancer Research or the company is not yet registered on the PEPPOL network.
When was Iqvia Cancer Research founded?
Iqvia Cancer Research was founded on 22-02-2021.
What is the address of Iqvia Cancer Research?
The current registered office of Iqvia Cancer Research is located at Da Vincilaan 7, 1930 Zaventem.
When was the last time Iqvia Cancer Research filed their annual financial statements?
The most recent financial statements of Iqvia Cancer Research were filed on 28-06-2025.
How many employees does Iqvia Cancer Research have?
There are currently no employees working at Iqvia Cancer Research or no workforce information is available.
What is the annual turnover of Iqvia Cancer Research?
At the time of its most recent financial statements, Iqvia Cancer Research did not publish any turnover figures. Iqvia Cancer Research reported a gross margin of €18,151.91.